During the past decade, Permanente Medical Group (060) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Permanente Medical Group (060)" #1 collaborator was "National Cancer Institute (NCI)" with 1 trials as a collaborator and "Susan G. Komen Breast Cancer Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Permanente Medical Group (060)" are "Breast Cancer" (2 trials), "Crohn's Disease" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Permanente Medical Group (060)" in a lesser frequency.

Most popular intervention types in "Permanente Medical Group (060)" are "Drug" (2 trials), "Behavioral" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "abatacept" (2 trials), "placebo" (2 trials), "therapeutic dietary intervention" (2 trials), "abatacept (ABA)" (1 trials) and "educational intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Permanente Medical Group (060)" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Permanente Medical Group (060)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Permanente Medical Group (060), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Permanente Medical Group (060), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".